PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer

ABSTRACT: The purpose of this study is to compare the concentration of four different metabolites in the tumor, in adjacent mucosa and in plasma in patients with colon cancer receiving two different doses of Modufolin (arfolitixorin) and Levoleucovorin (Isovorin), respectively (60 and 200 mg/m2).

DISEASE(S): Rectal Neoplasms,Colon Cancer,Colorectal Neoplasms,Neoplasms,Colonic Neoplasms

PROVIDER: 2131633 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR